TWST Form 144: Insider Plans Sale of 124 Shares Worth $3,615
Form 144 notice for Twist Bioscience Corp (TWST) shows an officer or insider, Dennis H. Cho, proposing to sell 124 common shares on 10/02/2025.
Rhea-AI Filing Summary
Form 144 notice for Twist Bioscience Corp (TWST) shows an officer or insider, Dennis H. Cho, proposing to sell 124 common shares on 10/02/2025. Those 124 shares were acquired the prior day, 10/01/2025, by restricted stock vesting as compensation. The filing lists the broker as Fidelity Brokerage Services LLC and indicates an aggregate market value of $3,615.95 for the shares to be sold. The issuer has 60,360,925 shares outstanding per the form. The filing also discloses six prior open-market sales by Dennis H. Cho from 07/02/2025 through 09/22/2025, totaling 2,027 shares and gross proceeds of $54,048.04 across those transactions. The filer certifies no undisclosed material adverse information.
Positive
- Full disclosure of acquisition method (restricted stock vesting) and sale dates
- Broker identified (Fidelity Brokerage Services LLC) and aggregate market value provided
- Prior sales listed with dates and gross proceeds totaling $54,048.04
Negative
- Insider selling shares (2,027 shares sold in the past three months plus 124 proposed sale)
- Proposed sale of newly vested shares on 10/02/2025 may increase free float
Insights
Insider sold newly vested shares and previously sold 2,027 shares this quarter.
The filing documents a small planned sale of 124 shares arising from restricted stock vesting on 10/01/2025, to be executed through Fidelity on 10/02/2025. The insider previously sold 2,027 shares between 07/02/2025 and 09/22/2025 for total gross proceeds of $54,048.04, which is fully disclosed in the form.
This is a routine disclosure under Rule 144 and the signer attests there is no undisclosed material adverse information.
FAQ
What does the TWST Form 144 disclose about the proposed sale?
Who is the selling person named in the Form 144?
What prior sales by the insider are disclosed in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.